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Abstract
Natural killer (NK) cells are lymphocytes that play a major role in the elimination of virally-infected cells and tumor cells.
NK cells recognize and target abnormal cells through activation of stimulatory receptors such as NKG2D. NKG2D ligands are
self-proteins, which are absent or expressed at low levels on healthy cells but are induced upon cellular stress,
transformation, or viral infection. The exact molecular mechanisms driving expression of these ligands remain poorly
understood. Here we show that murine cytomegalovirus (MCMV) infection activates the phosphatidylinositol-3-kinase (PI3K)
pathway and that this activation is required for the induction of the RAE-1 family of mouse NKG2D ligands. Among the
multiple PI3K catalytic subunits, inhibition of the p110a catalytic subunit blocks this induction. Similarly, inhibition of p110a
PI3K reduces cell surface expression of RAE-1 on transformed cells. Many viruses manipulate the PI3K pathway, and tumors
frequently mutate the p110a oncogene. Thus, our findings suggest that dysregulation of the PI3K pathway is an important
signal to induce expression of RAE-1, and this may represent a commonality among various types of cellular stresses that
result in the induction of NKG2D ligands.
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Introduction
Natural killer (NK) cells are specialized lymphocytes of the
innate immune system that target both tumor cells and virally-
infected cells. NK-cell cytotoxicity is regulated by a balance of
signaling through inhibitory and stimulatory receptors [1,2]. Most
of the inhibitory receptors generally recognize major histocom-
patibility complex I (MHC-I) molecules, a set of proteins often
downregulated during viral infection or tumorigenesis. Stimulatory
receptors recognize a wide variety of self-proteins that are induced
upon viral infection or cellular transformation. Together, a net
positive signal activates NK cells to secrete proinflammatory
molecules TNF-a and IFN-c, as well as effectors of lysis, granzy-
mes and perforin [3].
NKG2D is a well-studied and potent NK-stimulatory receptor
that is expressed on the surface of NK cells, activated CD8 T cells,
and subsets of cd T cells and NKT cells [4]. NKG2D can also
function as a co-stimulatory receptor to enhance T-cell activation
[5,6]. The human genome encodes at least seven NKG2D ligands
(MICA, MICB, ULBP1-4, and RAET1G), and the mouse genome
encodes at least nine NKG2D ligands (MULT-1, H60a-c, and
RAE-1a-e). Although the ligands bind NKG2D with varying
affinities, they all trigger NK cell killing of target cells similarly.
NKG2D ligand transcripts can be detected in certain cell types or
during specific phases of development, but in general, ligand
expression is low or absent in healthy cells [4]. However, ligands
are induced during various stress conditions including transfor-
mation, DNA damage, and viral infection. Accordingly, NKG2D
ligands are constitutively expressed on many tumor cell lines and
on a large array of tumors including melanomas, leukemias,
various carcinomas, and neuroblastomas [7,8]. NKG2D ligands
are also upregulated in cells infected with viruses such as
cytomegalovirus (CMV), measles, Influenza A, and respiratory
syncytial virus [9,10]. To counteract this NK recognition, tumors
and viruses have evolved ways to shed or block surface expression
of NKG2D ligands [11,12]. In particular, studies using mouse
CMV (MCMV) with deletion mutations in genes encoding
proteins that block ligand expression have shown that the ability
of the virus to evade NKG2D recognition has a significant
advantage on viral fitness in vivo [13–15]. Furthermore, aberrant
expression of NKG2D ligands can lead to unwanted NKG2D
signaling, which has been implicated in autoimmune diseases, such
as rheumatoid arthritis and type 1 diabetes [16]. Therefore,
regulation of ligand expression under different conditions is critical
to prevent targeting of healthy cells.
Several modes of regulation have been shown for NKG2D
ligand expression. At the transcriptional level, expression of
human NKG2D ligands MICA and MICB seems to be controlled
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genomic DNA also leads to increased expression of RAE-1,
MULT-1, ULBP1-3 and MICA, and RAE-1 induction occurs
through the action of ataxia telangiectasia mutated (ATM) and/or
ataxia telangiectasia and Rad3-related (ATR), as well as
checkpoint effector kinase1 (Chk1) [18]. Additionally, it was
reported that c-Myc regulates RAE-1e at the transcriptional level
[19]. At the post-transcriptional level, the expression of MICA and
MICB can be inhibited by cellular microRNAs, and MICB
expression can also be inhibited by viral microRNAs [20,21].
Finally, the expression of MULT-1 is regulated post-translationally
through ubiquitination [22].
The effect of NKG2D ligand expression on NK cell activity,
both in vitro and in vivo, has been best characterized with the RAE-1
family of mouse NKG2D ligands. Cells that normally do not
express NKG2D ligands become highly susceptible to NK cell-
mediated lysis in vitro when transduced with RAE-1 [8,23]. Ectopic
expression of RAE-1 in tumor cells also results in efficient
clearance of tumor cells after subcutaneous transfer in vivo.
Clearance in vivo is mediated by NK cells and in some cases
CD8 T cells, despite expression of inhibitory MHC-I molecules in
some tumor cells [6,24]. Together these data demonstrate that
RAE-1 expression results in NK-cell susceptibility both in vitro and
in vivo, and highlight the importance of understanding the
molecular mechanism of RAE-1 expression.
Despite some evidence showing the role of certain pathways and
effector molecules in the expression of NKG2D ligands, much
remains to be learned about the process, and uncovering the
molecular mechanism that drive expression of each of the
NKG2D ligands remains an active area of research in the field.
In particular, very little is known concerning the mechanisms of
RAE-1 induction in virus-infected cells. CMV infection results in
the induction of transcripts encoding numerous NKG2D ligands,
including RAE-1, MULT-1, and H60a in the mouse. However,
both human and mouse CMV encode proteins that specifically
inhibit expression of each of the NKG2D ligands at the protein
level, suggesting that NK cell recognition of CMV-infected cells
has put evolutionary pressure on the virus to evade this arm of the
immune system. The inducibility of RAE-1 in MCMV-infected
cells prompted us to use this well characterized virus to investigate
the molecular mechanism of RAE-1 induction. Strikingly, our
studies showed that virus-induced activation of phosphatidylino-
sitol-3-kinase (PI3K) is essential for the induction of the RAE-1
family of mouse NKG2D ligands. Further studies demonstrated
that PI3K is also important for the maintenance of RAE-1 and
MULT-1 expression on transformed cells, showing the breadth of
our findings. These results suggest that activation of the PI3K
pathway, which occurs in cells infected with numerous viruses and
in cancer cells, represents a common signal for regulating RAE-1
expression. Finally, the effect of PI3K inhibition on MULT-1
expression also reveals the possibility that PI3K activation may
play a role in regulating expression of other NKG2D ligands in
cells infected with other viruses and other pathologic states such as
inflammatory diseases.
Results
RAE-1 mRNA and protein are induced upon MCMV
infection
Most cell lines constitutively express varying levels of RAE-1 at
the cell surface [8]. Because most cells in vivo generally express very
low levels of NKG2D ligands, if any at all, we utilized established
mouse-tail fibroblasts that do not express RAE-1 at the surface to
investigate the mechanism of RAE-1 induction upon MCMV
infection. These fibroblasts have previously been used to demons-
trate RAE-1 induction upon activation of the DNA damage
response [18]. Upon infection of fibroblasts with MCMV for 24
hours, there was a significant induction of RAE-1 expression at the
RNA level (Fig. 1A). In order to further observe RAE-1 induction
at the cell surface, we utilized a MCMV mutant (MCMVD152)
lacking the m152 gene, which encodes an immune evasin that
downregulates RAE-1 protein. Using this virus, we observed RAE-
1 surface expression starting 18 hours post-infection with an even
higher expression at 24 hours post-infection (Fig. 1B). Importantly,
RAE-1 surface expression was not observed upon infection with
the revertant virus (MCMVD152-rev) at 24 hours post-infection,
despite no significant difference in the levels of RAE-1 mRNA
induction (Fig. 1C).
Although previous studies have demonstrated the ability of
MCMV to induce RAE-1 expression, it was not determined
whether induction occurs specifically in infected cells or also in
neighboring uninfected cells by an indirect mechanism. To
address this question, we distinguished infected versus uninfected
cells by staining cells with an antibody specific for an MCMV
protein, m157, that is expressed at the cell surface of infected cells
[25]. Co-staining experiments demonstrated that RAE-1 induction
occurs only in infected cells, suggesting that RAE-1 induction is a
direct consequence of infection (Fig. 1D). The m157-positive cells
that express RAE-1 at low levels are most likely cells that were
recently infected in the cultures and have not had sufficient time to
upregulate RAE-1. In subsequent experiments, we determined
which events associated with the viral life cycle are necessary for
RAE-1 induction.
Viral gene expression is necessary for RAE-1 induction
Upon entry, MCMV initiates a sequence of well-characterized
events including transcription of immediate early and early genes,
which are essential for viral replication and for the activation of
cellular pathways aimed at priming the cell for efficient viral
replication [26]. Expression of these early genes is also required for
the expression of late genes and subsequent packaging and
budding of the virus [27].
To investigate whether expression of viral genes is necessary
for RAE-1 induction, fibroblasts were infected with either
Author Summary
Human and mouse cytomegaloviruses (HCMV and MCMV)
are members of the Herpesvirus family. Both viruses
cause disease in individuals with a compromised immune
system, such as transplant patients and AIDS patients.
Natural killer (NK) cells are essential players in the immune
response against these viruses. NK cells recognize self-
proteins, such as NKG2D ligands, that are poorly expressed
on healthy cells but are upregulated on cells that are
undergoing stress, such as infection and tumor develop-
ment. The biological processes associated with NKG2D
ligand expression in infected cells are unknown. The PI3K
pathway, which controls many cellular processes, is
activated by a variety of viruses to prime cells for efficient
viral replication. We observed that MCMV activates the
PI3K pathway and that this activation is required for
NKG2D ligand expression. We also found that the
expression of NKG2D ligands on cancer cell lines is
dependent on this pathway. Our data suggest that NKG2D
ligand expression, and thus recognition of infected and
cancer cells by NK cells, is associated with a dysregulation
in the PI3K pathway.
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PLoS Pathogens | www.plospathogens.org 2 September 2011 | Volume 7 | Issue 9 | e1002265Figure 1. RAE-1 mRNA and protein are induced upon infection of mouse fibroblasts. A) The level of RAE-1 mRNA induction was
determined in MCMV-infected fibroblasts (WT) at 24 hrs post-infection (pi) using RT-qPCR. Fold induction was determined by normalizing the
infected samples to uninfected samples (NI). SD and statistical significance were determined from five independent samples. **p,0.01 compared to
NI. B) RAE-1 expression on the surface of fibroblasts infected with MCMVD152 for 4, 8, 12, 18 and 24 hrs pi was determined using a pan RAE-1
antibody. The data shown are gated on live, 7AAD negative cells. Histograms show isotype control (shaded gray), uninfected (dashed black), and
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inactivation significantly impaired the ability of MCMVD152 to
induce expression of RAE-1 both at the RNA and protein levels
throughout the course of the infection (Fig. 2A and B). Interferon-
Stimulated Gene 15 (ISG15) expression was significantly induced
upon infection by both MCMVD152 (D152) and UV-inactivated
virus (UV) (Fig. 2C), indicating that neither viral entry nor
activation of the interferon response was affected by the UV
treatment. As a control, MCMV early gene 1 (e1) product was
PCR amplified using viral genomic DNA extracted from either
MCMVD152 or UV-inactivated MCMVD152, and no amplifica-
tion was observed from the UV-inactivated viral genomic DNA
(data not shown). UV-inactivation was also confirmed by the lack
of plaque forming units in the supernatant of cells infected with
UV-inactivated virus for 24 hours (data not shown).
We next determined whether viral DNA replication is required
for the induction of RAE-1 using phosphonoacetic acid (PAA), a
chemical inhibitor that binds to the viral DNA polymerase and
blocks CMV viral replication [28]. Infection of fibroblasts with
MCMVD152 for 24 hours in the presence of PAA did not inhibit
RAE-1 induction, indicating that viral DNA replication and late
gene expression are dispensable for RAE-1 induction (Fig. 2D).
Altogether, our results suggest that expression of viral genes at an
early stage upon infection prior to viral replication is necessary for
the induction of RAE-1.
The DNA damage response is not required for RAE-1
induction by MCMV
Stress-induced activation of the DNA damage response,
through the action of ATM or ATR and Chk1, has been
implicated in the induction of RAE-1 and other NKG2D ligands
[18,29,30]. Additionally, CMV has been shown to manipulate the
DNA damage response [31,32]. Therefore, we tested the role of
the DNA damage response in the induction of RAE-1 in MCMV-
infected cells by infecting fibroblasts for 24 hours in the presence
or absence of specific inhibitors of the DNA damage response
pathway. Inhibition of Chk1 using SB218078 and UCN-01, or
inhibition of ATM/ATR using caffeine did not affect RAE-1
induction upon MCMV infection, indicating that activation of the
DNA damage response is not required for MCMV-induced RAE-
1 expression (Fig. S1).
RAE-1 induction requires activation of the PI3K pathway
Many cellular pathways are activated early on upon viral
infection to achieve a state of pro-survival and increased cellular
proliferation for optimal replication and production of progeny
virus [33]. Common cellular pathways activated upon viral
infections include the mitogen-activated protein kinase (MAPK)
and the phosphatidylinositol-3-kinase (PI3K) pathways [34,35].
The PI3K pathway, in particular, is crucial in controlling cell
growth and survival and is a key pathway in promoting cellular
transformation, another condition known to trigger NKG2D
ligand expression [36]. Because our data suggested that early
events upon viral infection are necessary to induce RAE-1, we
hypothesized that manipulation of some of these cellular pathways
are involved in the induction. To test this hypothesis, fibroblasts
were infected with MCMVD152 for 24 hours in the presence of
known inhibitors of these pathways, and RAE-1 surface expression
was analyzed. MCMV-induced RAE-1 induction was not affected
by the presence of MAPK inhibitors (Fig. S2). Remarkably
however, surface expression of RAE-1 was completely abrogated
in the presence of LY294002, a global inhibitor of PI3K that binds
to the catalytic domain of the kinase [37] (Fig. 3A). Viral titers in
the supernatant collected from cells infected for 24 hours in the
presence or absence of LY294002 were not significantly different,
indicating that the absence of RAE-1 surface expression was not
due to a lack of viral entry and replication (Fig. 3B). Of note, input
virus was removed two hours post-infection, and therefore, virus
present in the supernatant at 24 hours post-infection is a measure
of progeny virus produced as a result of infection and replication.
Furthermore, inhibitors were added at two hours post-infection to
fresh culture media to prevent possible blockage of viral
attachment or entry.
The requirement for active PI3K to induce RAE-1 suggests that
MCMV infection activates the PI3K pathway. To determine
whether the PI3K pathway is activated upon MCMV infection in
our system, cellular lysates from MCMV-infected fibroblasts were
analyzed by western blotting with an antibody specific for Akt
phosphorylated at Serine 473. As positive controls, whole cell
lysates were obtained from cells treated with 20% fetal bovine
serum (FBS) or cells stably expressing the catalytic subunit of PI3K
(p110a) with an H1047R mutation that renders PI3K constitu-
tively active [38]. Very little Akt phosphorylation was observed in
uninfected cells. By contrast, Akt phosphorylation was readily
detectable in MCMV-infected cells as well as in cells treated with
FBS and cells stably expressing p110a H1047R (Fig. 3C). When
cells were infected in the presence of LY294002, the phosphor-
ylated form of Akt was no longer detectable. Altogether, our data
indicate that MCMV infection activates the PI3K pathway, in
accordance with data obtained with HCMV [39], and that this
activation is required for the induction of RAE-1.
Signaling through p110a PI3K is essential for RAE-1
induction in MCMV-infected cells
There are three classes of enzymes in the PI3K superfamily,
class I, II, and III. Akt activation occurs mainly through class I
PI3K, and this is critical in regulating cell survival, metabolism,
apoptosis, and cell cycle. Class I PI3Ks are heterodimeric
molecules composed of a catalytic and a regulatory subunit and
are classified into class IA or class IB PI3K. The catalytic subunits
of class IA PI3K are p110a, b or d, whereas class IB PI3K contains
p110c [40]. It is becoming increasingly appreciated that PI3K
catalytic subunits play non-redundant roles in regulating the
biology of the cell [41]. Thus, we hypothesized that RAE-1
induction upon MCMV infection occurs through a particular
PI3K isoform such that a specific signal is required for its
expression.
In order to determine which of the PI3K isoforms are involved
in RAE-1 induction, we first determined the expression patterns of
each of the PI3K catalytic and regulatory subunits in our
fibroblasts at the steady state level by RT-PCR analysis. Our
analysis showed that all of the catalytic and regulatory subunits
were detected to varying degrees in these cells (Fig. 4A). We then
employed isoform-specific inhibitors to test the role of each of the
infected cells (solid black). C) RAE-1 surface expression on fibroblasts infected with MCMVD152 revertant (D152-rev) was analyzed using a pan RAE-1
antibody at 24 hrs pi. The level of RAE-1 mRNA in cells infected with D152 and D152-rev was quantified by RT-qPCR. Fold induction was determined
by normalizing the infected samples to uninfected samples (NI). The data in the figure are representatives of three independent experiments. NS, not
statistically significant. D) RAE-1 expression was determined in infected versus uninfected cells. Cells were infected with D152, D152-rev or WT virus
and co-stained for MCMV m157 and RAE-1 at 24 hrs pi.
doi:10.1371/journal.ppat.1002265.g001
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surface expression was greatly diminished when cells were infected
in the presence of inhibitors for p110a (PI3Kai2 and PI-103), but
not in the presence of inhibitors for p110b (TGX-221), p110d
(IC87114) or p110c (AS252424) (Fig. 4B). Similar to treatment
with LY294002, treatment with either PI3Kai2 or PI-103 did not
result in a significant change in the viral titer in the supernatant,
indicating that the loss of RAE-1 expression in these cells was not
due to the lack of viral entry or replication (Fig. 4C).
Compared to LY294002, PI-103 is much more selective for
p110a, but at higher concentrations it is still able to inhibit other
targets in the pathway, namely DNA-PK and mTORC1 [42].
Therefore, to rule out possible contributions from these molecules
on RAE-1 induction, selective inhibitors of DNA-PK and
mTORC1 (NU7026 and rapamycin, respectively) were tested in
the same assay. Neither NU7026 nor rapamycin treatment
inhibited RAE-1 induction, suggesting that indeed RAE-1
induction upon MCMV infection involves signaling specifically
through the p110a-containing PI3K (Fig. 4D). These results were
further confirmed using a wide range of inhibitor concentrations in
MCMV-infected cells (Fig. S3).
p110a PI3K is also important for the maintenance of
RAE-1 and MULT-1 on transformed cells
The gene encoding p110a is an oncogene that is commonly
mutated in human cancers [43,44]. These mutations in p110a
cause the PI3K pathway to be constitutively active, resulting in
cellular transformation and oncogenesis [45–47]. Because RAE-1
molecules, along with other mouse and human NKG2D ligands,
are frequently expressed on the surface of transformed cell lines as
well as in some tumors in vivo [7,8], we hypothesized that RAE-1
expression in transformed cells is also dictated by p110a PI3K
signaling. To test this hypothesis, we first tested the effect of
LY294002 treatment on three different types of transformed cell
lines that all constitutively express RAE-1 at the cell surface: A20
(a B lymphoma cell line), NIH 3T3 (adherent fibroblast cell line)
and YAC-1 (a T lymphoma cell line). Cell surface RAE-1
expression was susceptible to inhibition by LY294002 treatment in
all three cell lines tested (Fig. 5A), suggesting that RAE-1
expression in these cells also depends on active PI3K.
To test the role of specific PI3K isoforms on RAE-1 expression
in transformed cells, YAC-1 cells were treated with the same
isoform-specific inhibitors used in Figure 4B and Figure S3, at a
wide range of concentrations. RAE-1 surface expression was
measured at 24 hours post-treatment. Similar to the effect
observed in MCMV-infected cells, PI-103 treatment led to a
significant decrease in the expression of RAE-1, whereas treatment
with selective inhibitors of the other isoforms of PI3K (p110b, c,
and d) or an inhibitor of DNA-PK had no significant effect on
RAE-1 expression, even at high concentrations (Fig. 5B). In NIH
3T3 cells (Fig. 5C) and A20 cells (data not shown), we also
observed inhibition of RAE-1 expression by PI-103, but not by
inhibitors of other PI3K isoforms. The lack of response to
inhibitors that target the p110b, c, and d isoforms of PI3K strongly
indicates that signaling through p110a is specifically involved in
the expression of RAE-1 in transformed cells as well. We also
tested whether RAE-1 expression was impacted by rapamycin, an
inhibitor of mTORC1, a downstream effector of PI3K. Whereas
rapamycin did not inhibit RAE-1 expression in infected cells
(Fig. 4D), NIH 3T3 cells (Fig. 5C) or A20 cells (data not shown), it
did block RAE-1 expression in YAC-1 cells (Fig. 5B). These data
suggest that mTORC1 plays a role in supporting RAE-1
expression in some transformed cells but not in others or in
MCMV-infected fibroblasts.
In order to address whether the PI3K pathway regulates other
mouse NKG2D ligands, we determined the effect of PI3K
inhibition on expression of MULT-1 and H60a in NIH 3T3
cells, which constitutively express all three types of mouse NKG2D
ligands. Similar to the results with RAE-1, MULT-1 expression
was suppressed in NIH 3T3 cells treated with LY294002 or PI-
103, but not with the other inhibitors (Fig. 5C). In contrast, H60a
expression was not significantly affected by the inhibition of PI3K.
Altogether the data illustrate a specific role of p110a PI3K in
regulating RAE-1 and MULT-1 mouse NKG2D ligands in
transformed cells.
Discussion
Activation of NK cells through the interaction between
NKG2D and NKG2D ligand is critical in the clearance of tumor
cells, virally-infected cells, and stressed cells [1]. Although reports
have implicated various effector molecules in regulating NKG2D
ligand expression, the mechanism of ligand induction is still poorly
understood. Here, we show that dysregulation of the PI3K
pathway is a key signal required for expression of the RAE-1
family of NKG2D ligands during both infection and transforma-
tion and that it is further involved in the expression of another
mouse NKG2D ligand, MULT-1.
In this study, we used both mouse fibroblasts and primary
peritoneal macrophages to study the expression of the RAE-1
family members (Fig. 1 and Fig. S4). Because both macrophages
and fibroblasts are infected by MCMV in vivo, the use of both of
these cell types in vitro is informative [48]. We chose fibroblasts to
perform all of the experiments because MCMVD152-infected
macrophages do not express RAE-1 protein at the cell surface (Fig.
S4C). The absence of surface expression occurred despite efficient
infection of these cells, activation of the PI3K pathway, and a
strong induction of RAE-1 mRNA, suggesting a cell type-specific
block in a post-transcriptional step of RAE-1 biogenesis that does
not prevent PI3K activation (Fig. S4A, B, and D).
RAE-1 expression requires sensing of ‘‘patterns of
pathogenesis’’
Using fibroblasts, we observed that RAE-1 induction occurs only
in infected cells (Fig. 1D) and that this induction requires active viral
gene expression (Fig. 2). Because viral infections are often
accompanied by production of defective viral particles that do not
contain the entire viral genome, such specificity will presumably
spare cells infected with defective viral particles from NK-cell
mediated killing. This discrimination may be beneficial for the host
because cells exposed to defective viral particles contain nucleic
Figure 2. Viral early gene expression is necessary for the induction of RAE-1. Fibroblasts were infected with either MCMVD152 (D152) or
UV-inactivated MCMVD152 (UV) for 4, 12, and 24 hrs, and RAE-1 mRNA expression (A), RAE-1 cell surface expression (B), and ISG15 mRNA expression
(C) were determined using RT-qPCR and flow cytometry. Fold induction was determined by normalizing the infected samples to uninfected samples
(NI). SD and statistical significance were determined from three independent samples. *p,0.05 and **p,0.01. D) Fibroblasts were infected with
MCMVD152 in the presence of 100 ug/ml PAA and stained with a pan RAE-1 antibody. Histograms show isotype control (shaded gray), uninfected
(solid gray), MCMVD152-infected (solid black), and cells infected with MCMVD152 in the presence of PAA (dashed black). The histogram is a
representative figure of three independent experiments.
doi:10.1371/journal.ppat.1002265.g002
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(PAMPs) and activate innate immune sensors that induce
production of type-I IFN and other proinflammatory molecules.
Indeed, UV-inactivated MCMV is a potent activator of ISG15
(Fig. 2C). NK-mediated killing of these cells could potentially curtail
inflammatory cytokine production. Additionally, cells infected with
defective particles may also serve as good sources of antigens for
cross-presentation by antigen presenting cells.
Recently, Vance et al. described the principle that signals
associated with active bacterial infection and manipulation of the
Figure 3. PI3K pathway is required for RAE-1 induction in MCMV-infected cells through the activation of Akt. A) Fibroblasts infected
with MCMVD152 in the presence of 20 uM LY294002 were stained for RAE-1 at 24 hrs pi. Histograms show isotype control (shaded gray), uninfected
(solid gray), MCMVD152-infected (solid black), and MCMVD152-infected cells in the presence of LY294002 (dashed black). The histogram is a
representative figure from three independent experiments. B) Plaque forming units (PFU)/ml were determined in supernatants of infected cells in the
presence of DMSO or LY294002. SD and statistical significance were determined from three independent experiments. NS, not statistically significant.
C) Whole cell lysates from fibroblasts infected with MCMV WT in the presence of DMSO or LY294002 were obtained at 12 and 24 hrs pi. Lysates were
also obtained from cells treated with 20% FBS or cells overexpressing p110a H1047R. All samples were blotted for phospho-Akt S473 and total Akt.
The relative ratio of P-Akt to total Akt from the blot was determined. The data is a representative experiment from ten independent experiments.
doi:10.1371/journal.ppat.1002265.g003
PI3K Activation Is Required for RAE-1 Expression
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to activate the innate immune response [49]. Here, we illustrated
that UV-inactivated viral particles were sufficient to stimulate the
IFN response, but expression of RAE-1 proteins was absolutely
dependent on active infection and manipulation of the host cell
machinery; activation of PI3K signaling being one example of
such manipulation. Hence, PI3K activation appears to function as
a ‘‘pattern of pathogenesis’’ for induction of RAE-1 expression.
However, additional considerations described below, indicate that
PI3K activation is not sufficient for Rae1 induction, suggesting
that several signals may function cooperatively to induce RAE-1
expression.
Multiple signals are required for the expression of RAE-1
We observed that RAE-1 expression requires viral genes that
are expressed prior to viral replication, as demonstrated by the use
of UV-inactivated virus and PAA (Fig. 2). This may suggest that
viral early proteins are mediating the induction of RAE-1. Because
immediate early proteins are the first to be expressed upon
MCMV infection, we tested their role in the induction of RAE-1.
Overexpression of GFP-fused MCMV ie1, ie2, and ie3 proteins
alone or in combination did not lead to the induction of RAE-1
(Fig. S5), suggesting that although these proteins may play a role,
they are not sufficient for RAE-1 expression.
In this manuscript, we focused on the involvement of cellular
pathways that are activated during viral infection in the expression
of RAE-1. The PI3K pathway regulates cellular functions inclu-
ding metabolism, cell cycle progression, proliferation, and
apoptosis, and it is often dysregulated in infected and transformed
cells [34,50]. Class IA PI3K is generally activated through rece-
ptor tyrosine kinases (RTKs), which are receptors for growth
factors, cytokines, and hormones. If class IA PI3K activation alone
is sufficient to induce RAE-1 induction, it should occur in response
to many cellular stimuli independently of infection. To test this, we
stimulated cells for 24 hours with PDGF, which activates the well-
studied RTK, PDGF receptor. Despite robust activation of the
PI3K pathway, as illustrated by phosphorylation of Akt, RAE-1
induction did not occur (data not shown and Fig. S6A). Interes-
tingly, PDGF-R has been shown to be a cellular receptor for
HCMV [51]. Thus, the lack of RAE-1 induction with PDGF
treatment is consistent with our finding that viral gene expression
is absolutely necessary. Additionally, overexpression of a consti-
tutively active form of p110a, p110a H1047R, by itself was
insufficient to induce RAE-1 expression, again despite robust
activation of the PI3K pathway (Fig. S6B and 3C).
Together these results strongly suggest that RAE-1 induction
is tightly regulated such that expression of the main viral
immediate early proteins (ie1, ie2, and ie3) or activation of class
IA PI3K in the absence of infection are not sufficient to induce
ligand induction and that additional signals are likely required
for the induction. Future investigations are necessary to identify
these additional pathways that are necessary for RAE-1
induction.
The role of PI3K activation in regulating RAE-1 expression
To determine whether PI3K activation is involved in regulating
RAE-1 at the post-translational level, we stably expressed the
coding region of RAE-1a or RAE-1c isoform from an exogenous
promoter. The choice of these isoforms came from our observation
that they were induced upon MCMV infection at the RNA level
(Fig. S8A) and at the protein level, confirmed by the use of two
different mutant viruses lacking m152 (Fig. S8B and C). RAE-1
expression in these cells was not affected by LY294002 treatment,
arguing that trafficking of RAE-1 and sustained expression of
mature RAE-1 proteins at the cell surface is not dependent on
PI3K activation (Fig. S7B).
Notably, although LY294002 treatment of infected cells resulted
in a complete loss of RAE-1 expression at the cell surface (Fig. 3A),
RAE-1 mRNA was still induced five fold compared to uninfected
cells (Fig. S7A). Therefore, it is possible that the PI3K pathway
plays a role in regulating RAE-1 at least in part at the post-
transcriptional level, prior to trafficking to the surface. Activation
of PI3K can enhance cellular translation via formation of the
translation initiation complex containing eIF4E [52], raising the
possibility that RAE-1 is regulated at the translational level upon
PI3K activation. Nevertheless, LY294002 treatment reduced the
amount of RAE-1 mRNA in infected cells by three fold, suggesting
a possible role of PI3K in either transcription of the RAE-1 gene
or stabilization of RAE-1 mRNA as well. It has recently been
shown that transcripts of two human NKG2D ligands, MICA and
MICB, are regulated by several cellular microRNAs [20], raising
an additional possibility that PI3K regulates microRNAs that
target RAE-1.
The importance of PI3K signaling in transformed cells
and cancer cells
The gene encoding the p110a catalytic subunit of PI3K is often
mutated in mouse and human tumors so as to render PI3K
constitutively active, and thus functions as an oncogene [53].
Despite the involvement of p110b, c, and d isoforms in cancer,
p110a is the only catalytic subunit of PI3K found to be mutated in
tumors, suggesting a unique role of p110a in cellular transforma-
tion [41]. We observed that p110a PI3K is important for the
expression of RAE-1 in multiple transformed cell lines (Fig. 5). The
mechanism by which the different PI3K heterodimers mediate
their non-redundant functions is poorly understood [54]. It is
possible that the specificity of p110a is achieved at the cell surface
receptor level (i.e. RTKs or GPCRs) or by one of the downstream
effectors of PI3K. Nonetheless, the role of p110a PI3K in
regulating RAE-1 expression during both viral infection and
transformation is an intriguing finding that deserves further
investigation.
In this study, we also observed an effect of PI3K inhibition on
MULT-1 expression, but not H60a. The observed difference in
the requirement for PI3K signaling for expression of different
mouse NKG2D ligands is interesting and may have several
explanations. One possibility is that the difference reflects a
Figure 4. p110a PI3K is specifically involved in the induction of RAE-1 in fibroblasts infected with MCMV. A) Expression of PI3K catalytic
and regulatory domains of class IA and IB PI3K in mouse fibroblasts at the steady state level was determined by RT-PCR. Top gel shows amplification
of fibroblast cDNA and the bottom gel shows amplification of no RT controls. Size of the ladder is indicated in base pairs. B) Fibroblasts infected with
MCMVD152 in the presence 25 uM PI3Kai2, 1.25 uM PI-103, 5 uM TGX-221, 10 uM IC87114 or 10 uM AS252424 were surface stained for RAE-1 at
24 hrs pi. C) PFU/ml was determined in supernatants from cells infected in the presence of DMSO, PI3Kai2 or PI-103. SD and statistical significance
were calculated from three independent experiments. NS, not statistically significant. D) Fibroblasts infected with MCMVD152 in the presence of
10 uM NU7026 or 100 nM rapamycin were stained for RAE-1 at 24 hrs pi. All histograms show isotype control (shaded gray), uninfected (solid gray),
MCMVD152-infected cells in the presence of DMSO (solid black) or inhibitors (dashed black). All histograms are representative figures from three
independent experiments.
doi:10.1371/journal.ppat.1002265.g004
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respond to activated PI3K, whereas H60a responds to distinct
cellular cues or stress pathway mediators. The notion that
NKG2D ligands respond to different stress pathways was already
suggested by the finding that MULT-1 is unique among the mouse
NKG2D ligands in being regulated by stress associated with heat
shock or UV irradiation [22]. The possibility that H60a has
unique regulatory properties is also suggested by the sequence of
its 39 untranslated region (UTR), which is unusually long (3kb) in
comparison to those of RAE-1 and MULT-1 (400bp and 700bp,
respectively), suggesting that it may contain a unique set of
regulatory elements.
PI3K and its downstream mediators such as Akt and mTORC1
have been key targets in the development of cancer therapies [50].
In particular, chemical analogues of the inhibitors used in this
study are used in clinical studies as therapeutics for cancer. As
cancer drug development progresses, it will be important to take
into consideration the potential for these PI3K inhibitors to greatly
diminish NK-cell recognition and cytolysis of targets; especially
because NK cells are important for recognition and clearance of
tumor cells [2].
Here, we identified a common pathway between infected and
transformed cells that is required for expression of the RAE-1
family of mouse NKG2D ligands. The results of this study are the
first to demonstrate the role of the PI3K pathway in the expression
of NKG2D ligands or other events that sensitize cells for immune
recognition. Our data suggest that PI3K dysregulation in the
context of disease is a key signal sensed by cells for expression of
RAE-1. This study provides an important direction for future
investigations designed to elucidate how NKG2D ligand expres-
sion is regulated and how it is restricted to diseased cells.
Materials and Methods
Cells
Established tail-derived fibroblasts were prepared as described
previously [18]. Established fibroblasts, BALB/c 3T3 (ATCC,
CCL-163), NIH 3T3 (ATCC, CRL-1658), and BOSC (ATCC,
CRL-11270) cells were maintained in DMEM with 5% FBS and
1% penicillin and streptomycin. YAC-1s (ATCC, TIB-160) and
A20s were maintained in RPMI. Peritoneal macrophages obtained
from C57BL/6 mice were cultured overnight in RPMI with 10%
MCSF provided by Dr. Portnoy (UC Berkeley), 10% FBS, and 1%
penicillin and streptomycin.
Virus propagation, infection and titering
MCMVD152 and D152-rev viruses were generously provided
by Dr. Hill (Oregon Health and Science University, Oregon).
MCMVD152-GFP virus was kindly provided by Dr. Jonjic
(University of Rijeka, Croatia). MCMVWT (Smith strain) and
MCMVDm04+m06+m152 viruses were generously provided by
Dr. Koszinowski (Max von Pettenkofer-Institute, Munich, Ger-
many). All viruses were propagated in NIH 3T3 cells and titered in
BALB/c 3T3 cells. For all infection experiments, fibroblasts
were infected at MOI of 5, input virus removed at 2 hrs pi, and
infection was allowed to take place for a total of 24 hrs.
Supernatants were collected at the time of harvest at 24 hrs pi
and used for titering in BALB/c 3T3s. For UV-inactivation of the
virus, viral supernatant was placed directly under the UV light in a
sterile tissue culture hood for 30 minutes. To confirm successful
UV-inactivation, MCMV e1 gene was PCR amplified from viral
genomic DNA isolated from equal volumes of untreated or UV-
treated virus stock. Briefly, viral DNA was extracted from viral
supernatants by adding an equal volume of phenol/chloroform
followed by another round of chloroform extraction, and
isopropanol was used to precipitate the DNA. UV-inactivation
was further confirmed by performing a plaque assay on
supernatants obtained from cells infected with either untreated
or UV-treated virus.
Flow cytometry
Fibroblasts and 3T3 cells were harvested in 2 mM EDTA PBS
and stained with monoclonal anti-mouse pan-specific RAE-1,
RAE-1a/b/c, RAE-1b/d, RAE-1e, MULT-1, H60A or Rat
IgG2A isotype control (all purchased from R&D) followed by PE-
conjugated goat anti-rat IgG (Jackson ImmunoResearch Labora-
tories). YAC-1s, A20s, and peritoneal macrophages were first
incubated with an anti-mouse CD16/CD32 FcBlock (BD),
followed by pan RAE-1 antibody and FITC or PE-conjugated
anti-rat IgG2A antibody (BD). All samples were co-stained with 7-
AAD (BD). MCMV m157-specific monoclonal antibody (6H1.2.1)
was generously provided by Dr. Yokoyama (Washington Univer-
sity School of Medicine, MO).
Reverse transcription quantitative real-time PCR
RNA from fibroblasts and macrophages were extracted in
Trizol (Invitrogen), treated with RQ1 DNase (Promega), and total
RNA was reverse transcribed using oligo(dT)15 primer (Integrated
DNA Technologies) and SuperScriptII (Invitrogen) at 42uC for 50
minutes. cDNAs were analyzed using ABI7300 Real Time PCR
System. RAE-1 isoform specific primers were described previously
[55]. Primers for RAE-1 and ISG15 are described in the Table S1.
cDNAs from uninfected tail fibroblasts were used to amplify
regions within the catalytic and regulatory domains of class I PI3K
using primers described in the Table S1.
Inhibitor treatments
Inhibitors for all infection experiments were added to the
media 2 hrs pi to first allow viral attachment and entry, and they
were left in the culture media for the remainder of the 24 hr
infection. Phosphonoacetic acid (PAA) was purchased from
Sigma Aldrich and used at a final concentration of 100 ug/ml,
pH 7.4. YAC-1s were cultured in the presence of PI3K inhibitors
for 18 hrs. U0126, SB203580, SB600125, SB218078, UCN-01,
LY294002, Rapamycin, and NU7026 were purchased from
Calbiochem. PI3Kai2, PI-103, TGX-221, and AS252424 were
Figure 5. p110a PI3K is involved in the maintenance of RAE-1 and MULT-1 expression on transformed cells. A) A20, NIH 3T3 and YAC-1
tumor cells were treated with 20 uM LY294002 for 24 hrs and stained for RAE-1 at the cell surface. Histograms show isotype control (shaded gray),
untreated (solid black) and treated cells (dashed black). The histogram is a representative figure from multiple independent experiments. B) YAC-1
cells were treated with the indicated inhibitors at 10 uM, 5 uM, 2.5 uM, 1.25 uM, and 0.625 uM and surface stained for RAE-1. SD and statistical
significance were determined from three independent experiments. Statistical significance (** or *) on the bottom corresponds to PI-103 and the
ones on top correspond to rapamycin treatments. C) NIH 3T3 cells expressing RAE-1, MULT-1, and H60a were treated with the indicated inhibitors
for 24 hrs and stained for RAE-1, MULT-1 or H60a (20 uM LY294002, 1 uM PI-103, 1 uM TGX-221, 100 nM Rapamycin, 10 uM AS252424, 10 uM
IC87114, and 10 uM NU7026). Percent RAE-1 and ligand expression were determined by normalizing the MFI of RAE-1 or other ligands in inhibitor-
treated cells to the MFI of RAE-1 or other ligands in DMSO-treated cells. SD and statistical analyses were calculated from three independent
experiments. **p,0.01 and *p,0.05.
doi:10.1371/journal.ppat.1002265.g005
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from Sigma, and IC87114 was kindly provided by Dr.
Okkenhaug (Babraham Institute, Cambridge, UK). The final
concentrations of all of these inhibitors are stated in the figure
legends of the corresponding figures.
Constructs and transduction
The coding region of RAE-1a or c isoforms was cloned into a
retroviral vector, pBMN-IN. p110a H1047R was cloned into a
retroviral vector pMG-hygro. Retroviral supernatants were
obtained as described previously [56]. MCMV ie1, 2, and 3 fused
to GFP was cloned into pEGFP.N1 (Clontech) and transiently
transfected using Lipofectamine 2000 (Invitrogen).
Western blotting
Mouse fibroblasts or peritoneal macrophages were serum-
starved overnight and infected with MCMV in the presence of
DMSO or LY294002 or treated with PDGF (Sigma) for 24 hrs.
Fibroblasts transduced with empty vector or transduced with
p110a H1047R were serum-starved overnight. Cell lysates were
analyzed by western blotting for phospho-Akt S473 and Akt
according to manufacturer’s instructions (Cell Signaling). The
relative ratio of P-Akt to total Akt was determined using ImageJ.
Statistical analysis
A two-tailed, paired student t-test was performed on all samples
where statistical significance is indicated.
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the Panel on Euthanasia of the American
Veterinary Society. We have received approval for these
experiments from the UC Berkeley IACUC (R292).
Supporting Information
Figure S1 MCMVDm04+m06+m152-mediated induction
of RAE-1 is independent of the DNA damage pathway.
RAE-1 surface expression was determined in fibroblasts infected
with MCMV lacking m04, m06, and m152 (MCMVDm04
+m06+m152) in the presence of 150 nM SB218078, 70 nM
UCN-01 or 5 mM Caffeine. The data shown are gated on live,
7AAD negative cells. Histograms show isotype control (shaded
gray), uninfected (solid gray), MCMVDm04+m06+m152-infected
(solid black), and MCMVDm04+m06+m152-infected cells in the
presence of inhibitors (dashed black).
(PDF)
Figure S2 Erk and p38/Jnk activation is not required
for MCMV-mediated induction of RAE-1. Fibroblasts
infected with MCMVDm04+m06+m152 in the presence of
2 uM U0126 or 1 uM SB203580 and SB600125 were stained
with the pan RAE-1 antibody. The data shown are gated on live,
7AAD negative cells. Histograms show isotype control (shaded
gray), uninfected (solid gray), MCMVD3-infected (solid black), and
MCMVDm04+m06+m152-infected cells in the presence of
inhibitors (dashed black).
(PDF)
Figure S3 p110a PI3K is specifically involved in the
induction of RAE-1 in fibroblasts infected with MCMV.
Fibroblasts infected with MCMVDm04+m06+m152 in the
presence of the indicated inhibitors at 10 uM, 5 uM, 2.5 uM,
1.25 uM, and 0.625 uM were stained for RAE-1. The percent
RAE-1 expression was determined by normalizing the MFI of
RAE-1 in cells that were treated with the inhibitors to the MFI of
RAE-1 in cells that were treated with DMSO. SD and statistical
significance were determined from three independent experi-
ments. **p,0.01.
(PDF)
Figure S4 MCMV infection of peritoneal macrophages
does not induce RAE-1 surface expression. A) Peritoneal
macrophages from C57BL/6 mice were infected with GFP
expressing MCMVWT (WT-GFP) or MCMVD152 (D152GFP)
at moi 1 for 24 hrs. The level of GFP expression was determined
by flow cytometry. B) RAE-1 mRNA level in peritoneal macro-
phages infected with MCMVD152 (D152), MCMVD152-revertant
(D152-rev), MCMVD152-GFP (D152-GFP) or MCMVWT (WT)
was quantified by RT-qPCR and was normalized to the level
of HPRT for each sample. The data represent fold induction over
uninfected cells (NI). SD and statistical significance were
determined based on three independent experiments. **p,0.01.
C) RAE-1 surface expression in peritoneal macrophages infected
with D152 or D152-rev was determined by flow cytometry using a
pan RAE-1 antibody. D) Cellular lysates were obtained from
peritoneal macrophages infected with D152 or D152-rev for 24 hrs
in the presence of DMSO or LY294002 and used to probe for Akt
phosphorylation at serine 473 or total Akt. The blot is a
representative figure of three independent experiments.
(PDF)
Figure S5 Expression MCMV immediate early genes is
not sufficient to induce RAE-1 induction. Fibroblasts were
transiently transfected with GFP-fused MCMV ie1, 2, and 3 alone
or in combination (ie1+2+3) for 24 hrs and stained for RAE-1.
The data shown were gated on live, 7AAD negative cells.
(PDF)
Figure S6 Activation of PI3K by PDGF or overexpres-
sion of a constitutively active form of p110a does not
induce RAE-1 expression. Fibroblasts treated with (A) 20 ng/
ml of PDGF for 24 hrs or (B) stably expressing p110a H1047R
(constitutively active) were stained with the pan RAE-1 antibody.
The data shown are gated on live, 7AAD negative cells.
Histograms show isotype control (shaded gray), untreated (solid
black), and treated or empty vector (dashed black).
(PDF)
Figure S7 PI3K pathway is involved in post-transcrip-
tional regulation of RAE-1 upon MCMV infection. A) The
level of RAE-1 mRNA was determined in fibroblasts infected with
wildtype MCMV in the presence (WT+LY) or absence (WT) of
LY294002 using RT-qPCR at 24 hrs pi. Fold induction was
determined by normalizing the infected samples to uninfected
samples (NI). SD was determined from three independent
experiments. B) Fibroblasts stably transduced with RAE-1a or c
were treated with LY294002 for 24 hrs and stained with the RAE-
1abc-specific antibody. Histograms show isotype control (shaded
gray), DMSO-treated (solid black), and LY294002-treated cells
(dashed black).
(PDF)
Figure S8 Expression of RAE-1 isoforms is differentially
controlled in mouse fibroblasts infected with MCMV. (A)
RNA extracted from uninfected fibroblasts (NI) or fibroblasts
infected with MCMVDm04+m06+m152 (MCMVD3) were used
to quantify the expression levels of the RAE-1 isoforms using RT-
qPCR. Fold induction was determined by normalizing the infected
samples to uninfected samples (NI). SD was determined from two
independent experiments. ND; undetectable. Fibroblasts infected
with MCMVD3( B) or MCMVD152 (C) were surfaced stained
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PLoS Pathogens | www.plospathogens.org 12 September 2011 | Volume 7 | Issue 9 | e1002265with RAE-1 a/b/c, b/d or e antibody at 24 hrs pi. The data
shown were gated on live, 7AAD negative cells. Histograms show
isotype control (shaded gray), uninfected (dashed black), and
infected cells (solid black). The values represent the percent of live
RAE-1 positive cells.
(PDF)
Table S1 Primer sequences and product sizes. The table
contains primer sequences for all of the indicated target genes and
the corresponding expected product size for each primer set.
(DOC)
Acknowledgments
We would like to thank Dr. Koszinowski for MCMV WT and
Dm04+m06+m152 viruses, Dr. Hill for MCMVD152 and D152-revertant
viruses, Dr. Jonjic for MCMVD152-GFP, Dr. Yokoyama for the m157
antibody and Dr. Okkenhaug for the p110d inhibitor. We acknowledge the
CHPS mouse/virus core for virus production and titering.
Author Contributions
Conceived and designed the experiments: MT CL FD HJ DHR LC.
Performed the experiments: MT CL FD HJ. Analyzed the data: MT CL
DHR LC. Wrote the paper: MT DHR LC.
References
1. Raulet DH, Vance RE (2006) Self-tolerance of natural killer cells. Nat Rev
Immunol 6: 520–531.
2. Raulet DH, Guerra N (2009) Oncogenic stress sensed by the immune system:
Role of natural killer cell receptors. Nat Rev Immunol 9: 568–580.
3. Lodoen MB, Lanier LL (2006) Natural killer cells as an initial defense against
pathogens. Curr Opin Immunol 18: 391–398.
4. Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat
Rev Immunol 3: 781–790.
5. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, et al.
(2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by
MIC induced on virus-infected cells. Nat Immunol 2: 255–260.
6. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH (2001) Rae1 and H60
ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:
165–171.
7. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, et al. (1999) Broad
tumor-associated expression and recognition by tumor-derived gamma delta T
cells of MICA and MICB. Proc Natl Acad Sci U S A 96: 6879–6884.
8. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH (2000) Ligands for
the murine NKG2D receptor: Expression by tumor cells and activation of NK
cells and macrophages. Nat Immunol 1: 119–126.
9. Welte SA, Sinzger C, Lutz SZ, Singh-Jasuja H, Sampaio KL, et al. (2003)
Selective intracellular retention of virally induced NKG2D ligands by the human
cytomegalovirus UL16 glycoprotein. Eur J Immunol 33: 194–203.
10. Ebihara T, Masuda H, Akazawa T, Shingai M, Kikuta H, et al. (2007) Induction
of NKG2D ligands on human dendritic cells by TLR ligand stimulation and
RNA virus infection. Int Immunol 19: 1145–1155.
11. Salih HR, Rammensee HG, Steinle A (2002) Cutting edge: Down-regulation of
MICA on human tumors by proteolytic shedding. J Immunol 169: 4098–4102.
12. Jonjic S, Babic M, Polic B, Krmpotic A (2008) Immune evasion of natural killer
cells by viruses. Curr Opin Immunol 20: 30–38.
13. Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, et al. (2003)
NKG2D-mediated natural killer cell protection against cytomegalovirus is
impaired by viral gp40 modulation of retinoic acid early inducible 1 gene
molecules. J Exp Med 197: 1245–1253.
14. Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, et al. (2005) Selective
down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155
glycoprotein. J Virol 79: 2920–2930.
15. Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, et al. (2005) NK
cell activation through the NKG2D ligand MULT-1 is selectively prevented by
the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med
201: 211–220.
16. Van Belle TL, von Herrath MG (2009) The role of the activating receptor
NKG2D in autoimmunity. Mol Immunol 47: 8/11.
17. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, et al. (1996) Cell stress-
regulated human major histocompatibility complex class I gene expressed in
gastrointestinal epithelium. Proc Natl Acad Sci U S A 93: 12445–12450.
18. Gasser S, Orsulic S, Brown EJ, Raulet DH (2005) The DNA damage pathway
regulates innate immune system ligands of the NKG2D receptor. Nature 436:
1186–1190.
19. Unni AM, Bondar T, Medzhitov R (2008) Intrinsic sensor of oncogenic
transformation induces a signal for innate immunosurveillance. Proc Natl Acad
Sci U S A 105: 1686–1691.
20. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, et al. (2008) Human
microRNAs regulate stress-induced immune responses mediated by the receptor
NKG2D. Nat Immunol 9: 1065–1073.
21. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009) Diverse
herpesvirus microRNAs target the stress-induced immune ligand MICB to
escape recognition by natural killer cells. Cell Host Microbe 5: 376–385.
22. Nice TJ, Coscoy L, Raulet DH (2009) Posttranslational regulation of the
NKG2D ligand Mult1 in response to cell stress. J Exp Med 206: 287–298.
23. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, et al. (2000) Retinoic
acid early inducible genes define a ligand family for the activating NKG2D
receptor in mice. Immunity 12: 721–727.
24. Cerwenka A, Baron JL, Lanier LL (2001) Ectopic expression of retinoic acid
early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a
MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A 98:
11521–11526.
25. Tripathy SK, Smith HR, Holroyd EA, Pingel JT, Yokoyama WM (2006)
Expression of m157, a murine cytomegalovirus-encoded putative major
histocompatibility class I (MHC-I)-like protein, is independent of viral regulation
of host MHC-I. J Virol 80: 545–550.
26. Isaacson MK, Juckem LK, Compton T (2008) Virus entry and innate immune
activation. Curr Top Microbiol Immunol 325: 85–100.
27. Gibson W (2008) Structure and formation of the cytomegalovirus virion. Curr
Top Microbiol Immunol 325: 187–204.
28. Huang ES (1975) Human cytomegalovirus. IV. specific inhibition of virus-
induced DNA polymerase activity and viral DNA replication by phosphonoa-
cetic acid. J Virol 16: 1560–1565.
29. Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, et al. (2009) HIV-1 vpr
triggers natural killer cell-mediated lysis of infected cells through activation of the
ATR-mediated DNA damage response. PLoS Pathog 5: e1000613.
30. Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA (2010) HIV-1 vpr up-
regulates expression of ligands for the activating NKG2D receptor and promotes
NK cell-mediated killing. Blood 115: 1354–1363.
31. Shen YH, Utama B, Wang J, Raveendran M, Senthil D, et al. (2004) Human
cytomegalovirus causes endothelial injury through the ataxia telangiectasia
mutant and p53 DNA damage signaling pathways. Circ Res 94: 1310–1317.
32. Gaspar M, Shenk T (2006) Human cytomegalovirus inhibits a DNA damage
response by mislocalizing checkpoint proteins. Proc Natl Acad Sci U S A 103:
2821–2826.
33. Yurochko AD (2008) Human cytomegalovirus modulation of signal transduc-
tion. Curr Top Microbiol Immunol 325: 205–220.
34. Cooray S (2004) The pivotal role of phosphatidylinositol 3-kinase-akt signal
transduction in virus survival. J Gen Virol 85: 1065–1076.
35. Buchkovich NJ, Yu Y, Zampieri CA, Alwine JC (2008) The TORrid affairs of
viruses: Effects of mammalian DNA viruses on the PI3K-akt-mTOR signalling
pathway. Nat Rev Microbiol 6: 266–275.
36. Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: The
PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev
Cancer 6: 184–192.
37. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, et al. (2000)
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin,
LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909–919.
38. Zunder ER, Knight ZA, Houseman BT, Apsel B, Shokat KM (2008) Discovery
of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform
p110 alpha. Cancer Cell 14: 180–192.
39. Johnson RA, Wang X, Ma XL, Huong SM, Huang ES (2001) Human
cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway:
Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.
J Virol 75: 6022–6032.
40. Paez J, Sellers WR (2003) PI3K/PTEN/AKT pathway. A critical mediator of
oncogenic signaling. Cancer Treat Res 115: 145–167.
41. Vanhaesebroeck B, Vogt PK, Rommel C (2010) PI3K: From the bench to the
clinic and back. Curr Top Microbiol Immunol 347: 1–19.
42. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, et al.
(2006) A pharmacological map of the PI3-K family defines a role for p110alpha
in insulin signaling. Cell 125: 733–747.
43. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, et al. (2004) High frequency
of mutations of the PIK3CA gene in human cancers. Science 304: 554.
44. Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, et al. (2004) The
PIK3CA gene is mutated with high frequency in human breast cancers. Cancer
Biol Ther 3: 772–775.
45. Kang S, Bader AG, Vogt PK (2005) Phosphatidylinositol 3-kinase mutations
identified in human cancer are oncogenic. Proc Natl Acad Sci U S A 102:
802–807.
46. Ikenoue T, Kanai F, Hikiba Y, Obata T, Tanaka Y, et al. (2005) Functional
analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65:
4562–4567.
47. Samuels Y, Diaz LA, Jr., Schmidt-Kittler O, Cummins JM, Delong L, et al.
(2005) Mutant PIK3CA promotes cell growth and invasion of human cancer
cells. Cancer Cell 7: 561–573.
PI3K Activation Is Required for RAE-1 Expression
PLoS Pathogens | www.plospathogens.org 13 September 2011 | Volume 7 | Issue 9 | e100226548. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM (2009) Murine
cytomegalovirus displays selective infection of cells within hours after systemic
administration. J Gen Virol 90: 33–43.
49. Vance RE, Isberg RR, Portnoy DA (2009) Patterns of pathogenesis:
Discrimination of pathogenic and nonpathogenic microbes by the innate
immune system. Cell Host Microbe 6: 10–21.
50. Engelman JA (2009) Targeting PI3K signalling in cancer: Opportunities,
challenges and limitations. Nat Rev Cancer 9: 550–562.
51. Soroceanu L, Akhavan A, Cobbs CS (2008) Platelet-derived growth factor-alpha
receptor activation is required for human cytomegalovirus infection. Nature 455:
391–395.
52. Gingras AC, Raught B, Sonenberg N (1999) eIF4 initiation factors: Effectors of
mRNA recruitment to ribosomes and regulators of translation. Annu Rev
Biochem 68: 913–963.
53. Zhao L, Vogt PK (2008) Class I PI3K in oncogenic cellular transformation.
Oncogene 27: 5486–5496.
54. Vogt PK, Hart JR, Gymnopoulos M, Jiang H, Kang S, et al. (2010)
Phosphatidylinositol 3-kinase: The oncoprotein. Curr Top Microbiol Immunol
347: 79–104.
55. Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, et al. (2003)
Impairment of NK cell function by NKG2D modulation in NOD mice.
Immunity 18: 41–51.
56. Jarousse N, Coscoy L (2008) Selection of mutant CHO clones resistant to
murine gammaherpesvirus 68 infection. Virology 373: 376–386.
PI3K Activation Is Required for RAE-1 Expression
PLoS Pathogens | www.plospathogens.org 14 September 2011 | Volume 7 | Issue 9 | e1002265